Author: digi

Case Study: Risk-Based Reduction of Storage Time Points

Stability studies are resource-intensive and time-consuming, especially when following traditional, rigid time point schedules. However, applying risk-based approaches guided by ICH Q9 and ICH Q1A allows sponsors to scientifically reduce the number of storage time points without compromising data integrity or regulatory expectations. In this case-based article, we explore how one pharmaceutical company successfully implemented…

Pharmaceutical Quality and Practices, Risk-Based Approaches to Stability Testing

Best Practices for Periodic Review of Stability Data for Compliance

In pharmaceutical manufacturing, stability studies are more than regulatory formalities — they are critical indicators of product quality and shelf-life. However, it’s not enough to generate data; it must be reviewed periodically to ensure compliance with regulatory expectations and timely detection of deviations. This is where periodic review of stability data becomes essential. Regulatory bodies…

Regulatory Guidelines, Significant Changes and Data Integrity Compliance

Checklist for ICH Q1E Data Requirements in Submissions

ICH Q1E serves as the backbone of statistical evaluation for stability studies, particularly during regulatory submissions. Whether you are preparing a CTD Module 3 for a new drug application or submitting data for shelf life extension, this checklist will guide you through the key requirements outlined by ICH Q1E. Ensuring full compliance enhances credibility and…

ICH Q1E and Stability Data Evaluation, Protocols and Reports

ICH Q9 Integration in Stability Planning

Stability studies are a critical component of pharmaceutical product lifecycle management. With global regulatory bodies emphasizing a risk-based approach, integrating ICH Q9 Quality Risk Management (QRM) principles into stability planning has become essential for compliance, cost-efficiency, and scientific justification. This tutorial outlines a systematic way to implement ICH Q9 in designing, executing, and documenting stability…

Pharmaceutical Quality and Practices, Risk-Based Approaches to Stability Testing

SOP for Conducting Stability Testing for Advanced Therapy Medicinal Products (ATMPs) per EMA Guidelines

SOP for Conducting Stability Testing for Advanced Therapy Medicinal Products (ATMPs) per EMA Guidelines Guidelines for Stability Testing of ATMPs as per EMA Guidelines 1) Purpose The purpose of this Standard Operating Procedure (SOP) is to provide guidelines for conducting stability testing for Advanced Therapy Medicinal Products (ATMPs) in accordance with European Medicines Agency (EMA)…

Stability Studies SOP

Case Studies on Data Integrity Failures in Pharma Stability Labs

Data integrity is the cornerstone of trust in pharmaceutical manufacturing and stability testing. Yet, repeated global inspections continue to uncover alarming cases of falsification, manipulation, and cover-ups in stability laboratories. These failures not only jeopardize product quality and patient safety but also erode regulatory trust, resulting in import alerts, license suspensions, or even criminal charges….

Regulatory Guidelines, Significant Changes and Data Integrity Compliance

Accelerated vs. Real-Time Data in Shelf Life Prediction

Assigning accurate shelf life is a cornerstone of pharmaceutical product quality. Two key data sources support this prediction: real-time stability data and accelerated stability data. Both have distinct purposes and limitations, and their use must align with regulatory expectations. This tutorial-style article explains their differences and outlines how they are applied in building scientifically valid…

Shelf Life and Expiry, Shelf Life Prediction Models and Statistical Approaches

Understanding IQ, OQ, PQ Requirements for Chamber Calibration

In the pharmaceutical industry, calibration of equipment alone is not sufficient to meet global regulatory expectations. Stability chambers used for ICH condition testing must undergo a structured qualification process — known as IQ (Installation Qualification), OQ (Operational Qualification), and PQ (Performance Qualification). This tutorial provides a comprehensive understanding of these phases and their role in…

Equipment and Calibration, Stability Chamber Calibration and SOPs

How to Apply ICH Q1E for Stability Data Evaluation and Shelf Life Estimation

The ICH Q1E guideline plays a critical role in determining the shelf life of pharmaceutical products. It provides statistical approaches to evaluate long-term and accelerated stability data and supports shelf life extrapolation. In this tutorial, we’ll walk through how to apply ICH Q1E principles to evaluate your stability data effectively and ensure regulatory compliance. ✅…

ICH Q1E and Stability Data Evaluation, Protocols and Reports

What to Include in a Data Integrity Remediation Plan

Data integrity breaches can be devastating for pharmaceutical companies — triggering regulatory actions, import alerts, and even product recalls. When such issues arise, a robust data integrity remediation plan is essential for regaining regulatory trust and re-establishing GMP compliance. This guide walks you through what to include in a remediation plan that satisfies global agencies…

Regulatory Guidelines, Significant Changes and Data Integrity Compliance